| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3294783 | Gastroenterology | 2009 | 14 Pages |
Abstract
This is the first description of a chemokine-based antifibrotic pathway in the liver; antifibrotic therapies might be developed to modulate CXC chemokine levels.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Hermann E. Wasmuth, Frank Lammert, Mirko Moreno Zaldivar, Ralf Weiskirchen, Claus Hellerbrand, David Scholten, Marie-Luise Berres, Henning Zimmermann, Konrad L. Streetz, Frank Tacke, Sonja Hillebrandt, Petra Schmitz, Hildegard Keppeler, Thomas Berg,